Stopped: Logistical issues prevent efficient enrollment
Exparel is an FDA-approved local anesthetic (bupivacaine), in a long-release formulation. In this study the investigators plan to determine the ability of Exparel to control post-operative pain in common first metatarsophalangeal (MTP) joint procedures (bunion surgery, 1st MTP fusion, and cheilectomy).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Opioid Use as Measured by Questionnaire
Timeframe: Daily through the third day (72 hours) post-surgery
Total Opioid Use as Measured by Questionnaire
Timeframe: Daily through the third day (72 hours) post-surgery